These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 31812004)

  • 1. Simultaneous quantitative determination of seven novel tyrosine kinase inhibitors in plasma by a validated UPLC-MS/MS method and its application to human microsomal metabolic stability study.
    Ezzeldin E; Iqbal M; Herqash RN; ElNahhas T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Jan; 1136():121851. PubMed ID: 31812004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of a UPLC-MS/MS method for determination of motesanib in plasma: Application to metabolic stability and pharmacokinetic studies in rats.
    Ezzeldin E; Iqbal M; Al-Salahi R; El-Nahhas T
    J Pharm Biomed Anal; 2019 Mar; 166():244-251. PubMed ID: 30665192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous determination of selected tyrosine kinase inhibitors with corticosteroids and antiemetics in rat plasma by solid phase extraction and ultra-performance liquid chromatography-tandem mass spectrometry: Application to pharmacokinetic interaction studies.
    Maher HM; Alzoman NZ; Shehata SM
    J Pharm Biomed Anal; 2016 May; 124():216-227. PubMed ID: 26966895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Method development and validation for simultaneous determination of six tyrosine kinase inhibitors and two active metabolites in human plasma/serum using UPLC-MS/MS for therapeutic drug monitoring.
    Zhang M; Liu X; Chen Z; Jiang S; Wang L; Tao M; Miao L
    J Pharm Biomed Anal; 2022 Mar; 211():114562. PubMed ID: 35124453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous and rapid determination of 12 tyrosine kinase inhibitors by LC-MS/MS in human plasma: Application to therapeutic drug monitoring in patients with non-small cell lung cancer.
    Zhou L; Wang S; Chen M; Huang S; Zhang M; Bao W; Bao A; Zhang P; Guo H; Liu Z; Xie G; Gao J; Wu Z; Lou Y; Fan G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Jun; 1175():122752. PubMed ID: 33991955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous determination of nine tyrosine kinase inhibitors by 96-well solid-phase extraction and ultra performance LC/MS-MS.
    Bouchet S; Chauzit E; Ducint D; Castaing N; Canal-Raffin M; Moore N; Titier K; Molimard M
    Clin Chim Acta; 2011 May; 412(11-12):1060-7. PubMed ID: 21345336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of a sensitive liquid chromatography tandem mass spectrometry assay for the simultaneous determination of ten kinase inhibitors in human serum and plasma.
    Aghai F; Zimmermann S; Kurlbaum M; Jung P; Pelzer T; Klinker H; Isberner N; Scherf-Clavel O
    Anal Bioanal Chem; 2021 Jan; 413(2):599-612. PubMed ID: 33155133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a UPLC-MS/MS method for quantitation of metronidazole and 2-hydroxy metronidazole in human plasma and its application to a pharmacokinetic study.
    Stancil SL; van Haandel L; Abdel-Rahman S; Pearce RE
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Aug; 1092():272-278. PubMed ID: 29933220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eco-Friendly, Simple, Fast, and Sensitive UPLC-MS/MS Method for Determination of Pexidartinib in Plasma and Its Application to Metabolic Stability.
    Ezzeldin E; Iqbal M; Asiri YA; Mostafa GAE; Sayed AYA
    Molecules; 2022 Jan; 27(1):. PubMed ID: 35011540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous determination of six tyrosine kinase inhibitors in human plasma using HPLC-Q-Orbitrap mass spectrometry.
    Ni MW; Zhou J; Li H; Chen W; Mou HZ; Zheng ZG
    Bioanalysis; 2017 Jun; 9(12):925-935. PubMed ID: 28617069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. UPLC-MS/MS determination of phentolamine in human plasma and its application to a pharmacokinetic study.
    Kan X; Zheng SL; Zhou CY
    Drug Res (Stuttg); 2014 Nov; 64(11):607-12. PubMed ID: 24452521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and Validation of a Simultaneous Quantification Method of 14 Tyrosine Kinase Inhibitors in Human Plasma Using LC-MS/MS.
    Huynh HH; Pressiat C; Sauvageon H; Madelaine I; Maslanka P; Lebbé C; Thieblemont C; Goldwirt L; Mourah S
    Ther Drug Monit; 2017 Feb; 39(1):43-54. PubMed ID: 27861317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of Pralsetinib in Human Plasma and Cerebrospinal Fluid for Therapeutic Drug Monitoring by Ultra-performance Liquid Chromatography-Tandem Mass Spectrometry (UPLC-MS/MS).
    Zhao Z; Pu Q; Sun T; Huang Q; Tong L; Fan T; Kang J; Chen Y; Zhang Y
    Anticancer Agents Med Chem; 2024; 24(11):867-877. PubMed ID: 38584556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid determination of ruscogenin in rat plasma with application to pharmacokinetic study.
    Ji PY; Li ZW; Yang Q; Wu R
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Mar; 985():71-4. PubMed ID: 25660717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel high-performance liquid chromatography-tandem mass spectrometry method for simultaneous quantification of BCR-ABL and Bruton's tyrosine kinase inhibitors and their three active metabolites in human plasma.
    Mukai Y; Yoshida T; Kondo T; Inotsume N; Toda T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Jan; 1137():121928. PubMed ID: 31877431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous determination of tanshinones and polyphenolics in rat plasma by UPLC-MS/MS and its application to the pharmacokinetic interaction between them.
    Ren H; Qian D; Su S; Guan H; Zhang W; Shang E; Duan J
    Drug Test Anal; 2016 Jul; 8(7):744-54. PubMed ID: 26382027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A rapid UHPLC-MS/MS method for the quantification of ARQ531 in rat plasma: Validation and its application to a pharmacokinetic study.
    Liu J; Ji M; Li Z; Xu X; Li L; Li H; Tian Y; Su X
    Biomed Chromatogr; 2020 Nov; 34(11):e4937. PubMed ID: 32614971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a sensitive LC-MS/MS method for simultaneous determination of eight tyrosine kinase inhibitors and its application in mice pharmacokinetic studies.
    He Y; Zhou L; Gao S; Yin T; Tu Y; Rayford R; Wang X; Hu M
    J Pharm Biomed Anal; 2018 Jan; 148():65-72. PubMed ID: 28965046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective quantification of 11 tyrosine kinase inhibitors and caffeine in human plasma by validated LC-MS/MS method with potent phospholipids clean-up procedure. Application to therapeutic drug monitoring.
    Koller D; Vaitsekhovich V; Mba C; Steegmann JL; Zubiaur P; Abad-Santos F; Wojnicz A
    Talanta; 2020 Feb; 208():120450. PubMed ID: 31816725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification and analyses of seven tyrosine kinase inhibitors targeting hepatocellular carcinoma in human plasma by QuEChERS and UPLC-MS/MS.
    Liang Y; Li Y; Song L; Zhen X; Peng J; Li H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Jul; 1242():124217. PubMed ID: 38924946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.